This NDC is on FDA's drug shortage list (posted Jan 1, 2012)
Reported reason: Other
Product Information
FENTANYL 100 MCG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.7864 per ML under NDC 63323080602. Its NADAC has been published 192 times since Aug 4, 2021.
FDA first approved this application on May 3, 2019. Its Orange Book therapeutic-equivalence code is AP.
Strength
.05 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323080602
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
FENTANYL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA210762FDA Approved
5/3/2019
TE Code
AP
On Market Since
5/3/2019
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL 100 MCG/2 ML VIAL has been published 192 times since Aug 4, 2021, and over the history we have for it it has risen 171.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7864 per ML |
|---|---|
| All-time high | $1.7864 (Sep 30, 2026) |
| All-time low | $0.6264 (Apr 20, 2022) |
| 52-week high | $1.7864 |
| 52-week low | $1.0131 |
| Median price | $0.7444 |
| Average price | $0.8777 |
| Largest weekly change | +16.1% (Sep 17, 2025) |
| Weeks tracked | 192 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fentanyl Citrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENTANYL 100 MCG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL 100 MCG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.7864 per ML (NDC 63323080602), effective Sep 30, 2026.
How has the price of FENTANYL 100 MCG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FENTANYL 100 MCG/2 ML VIAL has risen 171.9%. It has been tracked across 192 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for FENTANYL 100 MCG/2 ML VIAL?
Since Aug 4, 2021, the NADAC for FENTANYL 100 MCG/2 ML VIAL has ranged from a low of $0.6264 (Apr 20, 2022) to a high of $1.7864 (Sep 30, 2026), with a median of $0.7444 per ML.
Are there cheaper alternatives to FENTANYL 100 MCG/2 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FENTANYL 100 MCG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures FENTANYL 100 MCG/2 ML VIAL?
FENTANYL 100 MCG/2 ML VIAL (NDC 63323080602) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is FENTANYL 100 MCG/2 ML VIAL in shortage?
Yes — NDC 63323080602 is currently listed in FDA's drug shortage database (posted Jan 1, 2012). Reported reason: Other.